Naser Mohamad Karimi

Jewish General Hospital

Papers

1

Total Citations

5

H-Index

1

About

Naser Mohamad Karimi is a forward-thinking oncologist whose research focuses on transforming treatment paradigms for head and neck cancers, with a particular emphasis on HPV-positive disease. His most cited work, "Rethinking treatment paradigms: Neoadjuvant therapy and de-escalation strategies in HPV-positive head and neck cancer" (2024), has already garnered 5 citations, signaling its early impact in reshaping clinical approaches. Karimi’s major contributions lie in advocating for less aggressive, personalized therapies that reduce long-term toxicity while maintaining efficacy—a critical shift for younger, HPV-positive patients. By exploring neoadjuvant strategies and de-escalation protocols, he challenges conventional standards, aiming to improve quality of life without compromising survival outcomes. His work bridges oncology and patient-centered care, offering a blueprint for future trials. Though early in his career, Karimi’s insights are gaining traction, positioning him as an emerging voice in precision oncology. His dedication to rethinking established norms underscores a commitment to innovation, making his research a vital resource for students and clinicians seeking to understand the next frontier in head and neck cancer treatment.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Rethinking treatment paradigms: Neoadjuvant therapy and de-escalation strategies in HPV-positive head and neck cancer
5 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Jewish General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago